Pierre-Aurelien Beuriat1,2, Arnault Tauziede-Espariat3, Melanie Pages3,4, Pascalae Varlet3,4, Federico Di Rocco5,6. 1. Department of Pediatric Neurosurgery, Necker-Enfants Malades Hospital, 149 Rue de Sèvres, 75015, Paris, France. pierre-aurelien.beuriat@neurochirurgie.fr. 2. Department of Pediatric Neurosurgery, Neurological and Neurosurgical Hospital Pierre Wertheimer, 59 Boulevard Pinel, 69677, Lyon Cedex, France. pierre-aurelien.beuriat@neurochirurgie.fr. 3. Department of Neuropathology, Sainte-Anne Hospital, 75674, Paris, Cedex 14, France. 4. Paris Descartes University, 12 Rue de l'École de Médecine, 75006, Paris, France. 5. Department of Pediatric Neurosurgery, Necker-Enfants Malades Hospital, 149 Rue de Sèvres, 75015, Paris, France. 6. Department of Pediatric Neurosurgery, Neurological and Neurosurgical Hospital Pierre Wertheimer, 59 Boulevard Pinel, 69677, Lyon Cedex, France.
Abstract
INTRODUCTION: Rosette-forming glioneuronal tumors (RGNTs) that do not involve the fourth ventricle are rare. RGNTs were originally thought to be exclusively localized into the fourth ventricle but were found in various anatomical localizations. MATERIAL AND METHODS: We review the literature and found 32 cases of this particular RGNT. The outcome was excellent with no mortality reported after surgical treatment. Only two patients had received adjuvant therapy for progression. We added one case of a RGNT located in the cerebellar hemisphere. CASE AND CONCLUSION: She underwent a subtotal removal with no evidence of progression after. This WHO grade I tumor with a specific biphasic histopathology is of a good oncological outcome after surgical treatment. A long follow-up is needed as recurrence or metastatic progressions exist.
INTRODUCTION: Rosette-forming glioneuronal tumors (RGNTs) that do not involve the fourth ventricle are rare. RGNTs were originally thought to be exclusively localized into the fourth ventricle but were found in various anatomical localizations. MATERIAL AND METHODS: We review the literature and found 32 cases of this particular RGNT. The outcome was excellent with no mortality reported after surgical treatment. Only two patients had received adjuvant therapy for progression. We added one case of a RGNT located in the cerebellar hemisphere. CASE AND CONCLUSION: She underwent a subtotal removal with no evidence of progression after. This WHO grade I tumor with a specific biphasic histopathology is of a good oncological outcome after surgical treatment. A long follow-up is needed as recurrence or metastatic progressions exist.
Authors: Bernd W Scheithauer; Ana I Silva; Rhett P Ketterling; J H Pula; James F Lininger; Mark J Krinock Journal: Neurosurgery Date: 2009-04 Impact factor: 4.654
Authors: David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues Journal: Acta Neuropathol Date: 2007-07-06 Impact factor: 17.088
Authors: Annika Schlamann; André O von Bueren; Christian Hagel; Isabella Zwiener; Clemens Seidel; Rolf-Dieter Kortmann; Klaus Müller Journal: PLoS One Date: 2014-07-03 Impact factor: 3.240
Authors: Caleb P Wilson; Arpan R Chakraborty; Panayiotis E Pelargos; Helen H Shi; Camille K Milton; Sarah Sung; Tressie McCoy; Jo Elle Peterson; Chad A Glenn Journal: Neurooncol Adv Date: 2020-09-09